Pakistan has an approximate of 12 million cases of hepatitis B and C (HBV/HCV) and ranks second among the league of nations when it comes to the prevalence of Hepatitis C, only after Egypt. Viral hepatitis B and C, causing chronic liver disease, complications and death, are a major concern for Pakistan. On 28 July 2021, VFAHT RMU organized a Hepatitis Screening Camp at Panah Gaah, Holy Family Hospital, Rawalpindi. The participants also indulged in a Hepatitis Awareness Walk led by Prof Muhammad Umar (Vice Chancellor, RMU). This activity aimed to raise awareness about the gravity of hepatitis spread and preventive measures.
The team showed full adherence to COVID-19 SOPs during the camp.
Table 01: Hepatitis B & C Screening
Screening Test Method
HBV and HCV RDTs (Rapid Diagnostic Testing Kits)
Population Age Range (Years)
No. of Population Screened
HBV PCR +ve
HCV PCR +ve